Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Hemorrhage 5Hematologic Neoplasms 3Head and Neck Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Osteosarcoma 1Myofibroma 1Metrorrhagia 1Meningioma 1Melanoma 1Leiomyoma 1Glioma 1Breast Neoplasms 1Astrocytoma 1

Interventions

relugolix 8ulipristal acetate 7telapristone acetate 7estradiol, norethindrone drug combination 7vilaprisan 6asoprisnil 6Estradiol 5linzagolix 4elagolix 4Norethindrone Acetate 3Leuprolide 3Sugars 2Progestins 2epigallocatechin gallate 1Uterine Myomectomy 1Uterine Artery Embolization 1Tranexamic Acid 1Tea 1Standard of Care 1Sodium Chloride 1Saline Solution 1Misoprostol 1Mifepristone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Laparoscopy 1Iron 1Hysterectomy 1Goserelin 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leiomyoma × Tranexamic Acid × Clear all
NCT04311073 2023-09-11

Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Eastern Virginia Medical School

Phase 3 Unknown
50 enrolled

Leiomyoma, Metrorrhagia, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡